Verrica Pharmaceuticals Inc (NASDAQ:VRCA) reported a 25.4% increase in U.S. Ycamp product revenue compared to the first quarter of 2025. The company achieved a significant milestone with the launch of ...

Good day, ladies and gentlemen, and welcome to the Verrica Pharmaceuticals First Quarter 2026 Earnings Conference Call. [Operator Instructions] As a reminder, this conference is being recorded. I will ...

Needham analyst Serge Belanger maintained a Hold rating on Verrica Pharmaceuticals today. The company’s shares closed last Wednesday at $5.91. According to TipRanks.com, Belanger is a 5-star analyst ...

VRCA Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Verrica Pharmaceuticals Inc. – VRCA Rosen Law Firm, a global investor rights ...

Good morning, ladies and gentlemen, and welcome to the Verrica Pharmaceuticals Fourth Quarter and Year-End 2025 Corporate Update Conference Call. [Operator Instructions] As a reminder, this conference ...

Total Revenue (Q4 2025): $5.1 million, up from $0.3 million in Q4 2024. Net YCANTH Revenue (Q4 2025): $3.7 million, compared to $0.3 million in Q4 2024. Torii Collaboration Revenue (Q4 2025): $1.4 ...

The IRS shut down its direct filing program for 2026, but Free File, Fillable Forms, MilTax, and some private tools remain—if you know where to look. Here’s how to navigate the free options still ...

(NEXSTAR) – In 2025, nearly 300,000 Americans used a new electronic system to file their taxes directly with the IRS for free. In 2026, that’s no longer an option. IRS Direct File launched as a pilot ...

WASHINGTON – The Justice Department has released hundreds of thousands of documents dealing with convicted sex offender Jeffrey Epstein, often with what women who accused him of abuse call “abnormal” ...

WASHINGTON – Revelations about President Donald Trump's travel, information about accused sex trafficker Jeffrey Epstein's injury before he died by suicide and a discussion about "co-conspirators" ...

Graham Kates is an investigative reporter covering criminal justice, privacy issues and information security for CBS News Digital. Contact Graham at KatesG@cbsnews.com or grahamkates@protonmail.com ...

Fintel reports that on December 18, 2025, Brookline Capital upgraded their outlook for Verrica Pharmaceuticals (NasdaqCM:VRCA) from Hold to Buy. Analyst Price Forecast Suggests 106.19% Upside As of ...